Chernett Jorey 4
4 · Oncology Institute, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Oncology Institute (TOI) 10% Owner Jorey Chernett Buys Shares
What Happened Jorey Chernett, reported as a 10% owner of Oncology Institute, Inc. (TOI), made three open-market purchases (Code P) totaling 398,985 shares between March 13 and March 17, 2026. Transactions reported: 263,000 shares on 2026-03-13 at a weighted avg price of $2.92 ($767,960); 60,985 shares on 2026-03-16 at $3.29 ($200,641); and 75,000 shares on 2026-03-17 at $3.42 ($256,500). Combined value of the reported buys is about $1,225,101. These are outright purchases (buys), not sales or option exercises.
Key Details
- Dates & reported prices:
- 2026-03-13: 263,000 shares @ $2.92 — $767,960 (Footnote F1: purchases in multiple fills at $2.77–$3.34; $2.92 is weighted avg).
- 2026-03-16: 60,985 shares @ $3.29 — $200,641 (F2: fills ranged $3.25–$3.43).
- 2026-03-17: 75,000 shares @ $3.42 — $256,500 (F3: fills ranged $3.39–$3.49).
- Total purchased: 398,985 shares for ~ $1.23M.
- Shares owned after the transactions: not specified in the provided data; filing identifies Chernett as a 10% beneficial owner.
- Footnotes: Prices shown are weighted averages; the filer offers to provide the breakdown of shares bought at each separate price on request (per F1–F3).
- Filing/timeliness: Form 4 filed 2026-03-17 reporting transactions from 2026-03-13 to 2026-03-17. No late-filing flag was indicated in the provided information.
Context
- These were open-market purchases (Code P), meaning shares were bought on the market rather than received via award or option exercise.
- As a 10% beneficial owner, Chernett is a large shareholder rather than necessarily an executive; such buys indicate additional insider ownership but do not alone explain motivation. This summary is factual and does not speculate on intent.
Insider Transaction Report
Form 4
Chernett Jorey
10% Owner
Transactions
- Purchase
Common Stock
[F1]2026-03-13$2.92/sh+263,000$767,960→ 10,115,944 total - Purchase
Common Stock
[F2]2026-03-16$3.29/sh+60,985$200,641→ 10,176,929 total - Purchase
Common Stock
[F3]2026-03-17$3.42/sh+75,000$256,500→ 10,251,929 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $2.77 to $3.34, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
- [F2]The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.43, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
- [F3]The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.39 to $3.49, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
Signature
/s/ Jorey Chernett|2026-03-17